skip top navigation
Cancer.gov
Skip to Content National Cancer Institute Cancer Control and Population Sciences
 SRAB logo
Statistical Research & Applications
About SRAB Research | Methods & Software | Funded Research | Publications   

Limited-Duration Prevalence

Limited-Duration Prevalence represents the proportion of people alive on a certain day who had a diagnosis of the disease within the past x years (e.g. x = 5, 10 or 20 years). Registries of shorter duration, less than 40 or 50 years of data collection, can only estimate limited-duration prevalence.

Limited-duration prevalence can be further classified into periods from year of diagnosis. Thus, the 20-years prevalence can be further classified into the prevalence of those diagnosed in the last 0 to < 5 years, 5 to < 10 years, 10 to < 15 years, and 15 to < 20 years.

NCI's SEER Program has information on cancer cases since 1973; however, prevalence calculations usually begin in 1975 due to a different number of registries participating in years 1973-1974. Thus a maximum of 25-year prevalence can be estimated from SEER using data from 1975 through 1999.

 

Prevalence Statistics:

* Overview
* Approaches to Estimation
* Available Prevalence Estimates
 

Definitions:

* Tumors Included in Prevalence Estimates
* Complete Prevalence
* Limited-Duration Prevalence
* Care and Cure Prevalence
 

Cancer Query Systems:

* Cancer Prevalence Database
* Probability of Developing or Dying of Cancer
* SEER Incidence & US Mortality Statistics

 Surveillance Research | Cancer Statistics Branch | Statistical Research & Applications Branch

  Search | Contact SRAB | Accessibility | Privacy Policy